Medscape July 15, 2024
Marilynn Larkin

An artificial-intelligence (AI)-enabled system of wearable coils and ingestible “smart” pills shows promise for identifying and tracking gasses in the gastrointestinal (GI) tract associated with digestive disorders, new research revealed.

Traditional methods for locating, measuring, and monitoring gasses associated with such disorders as irritable bowel syndrome, inflammatory bowel disease, food intolerances, and gastric cancers are often invasive and typically require hospital-based procedures.

This experimental system, developed by a team at the University of Southern California’s Viterbi School of Engineering, Los Angeles, represents “a significant step forward in ingestible technology,” according to principal investigator Yasser Khan, PhD, and colleagues.

The novel ingestible could someday serve as a “Fitbit for the gut” and aid in early disease detection, Khan said.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Patient / Consumer, Provider, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article